Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphorylated p68 refers to the post-translationally modified form of the p68 RNA helicase (DDX5), a DEAD-box family member. Phosphorylation, particularly at residues like Tyr593, modulates p68's activity, RNA binding, and interactions, impacting RNA metabolism, gene expression, and cancer progression. It is a potential therapeutic target in diseases with aberrant phosphorylation.
Inhibition of helicase activity, disruption of protein-protein interactions, modulation of phosphorylation status.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphorylated p68 RNA Helicase (p-p68).